article thumbnail

Listicle: Maximising outsourcing models beyond time and cost

Drug Discovery World

For these reasons and others, many biotech and pharmaceutical companies – along with government research labs and academic institutions – rely on contract research organizations (CROs) for drug discovery services. Designing DEL libraries has benefited from the development of AI to model compounds based on binding pockets. Conclusion.

Reagent 52
article thumbnail

Private equity firms play ‘pass the Parexel’ with $8.5bn handover deal

pharmaphorum

billion to claim ownership of the contract research organisation. The new deal will assists the company’s focus “on advancing and innovating Parexel to meet our customers’ needs across the evolving clinical development landscape,” he added.